Literature DB >> 11441274

Assessment of quality of life in cancer patients: complexity, criticism, challenges.

M Grumann1, P M Schlag.   

Abstract

Over the past two decades, quality of life (QoL) research has become an integral endpoint in clinical trials, yet, regarding its implementation in daily clinical work, much hesitation still abounds. This article discusses how complex psychological processes at work within a patient along with environmental factors act upon each other to form what is finally measured in a QoL score. An extended model of QoL is suggested which comprehensively describes the contribution of factors such as common psychological reactions to cancer, coping mechanisms, traits, and socioeconomic conditions to the final outcome in a QoL inventory. In order to avoid disappointment at the utility of results gained in QoL assessment both in clinical trials and daily routine, the choice of appropriate QoL instruments, their goal-directed implementation, and suitable expectations towards the anticipated aims are pivotal aspects to be ensured. Competent utilization of QoL assessment contributes to an enhanced standard of patient-centered care in oncology. Copyright 2001 S. Karger GmbH, Freiburg

Entities:  

Mesh:

Year:  2001        PMID: 11441274     DOI: 10.1159/000050275

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  3 in total

1.  [Quality of life after rectal surgery].

Authors:  S Hoppe De Mamani; P M Schlag
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Present status of known and possible outcomes in neurosurgery: a survey of outcome assessment.

Authors:  Wuttipong Tirakotai; Saranya Lapanich; Thomas Riegel; Dieter Hellwig; Helmut Bertalanffy; Ilhan Celik
Journal:  Childs Nerv Syst       Date:  2007-03-24       Impact factor: 1.532

3.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.